FABTECH · Healthcare · Health Information Services
Composite scorecard: 54/100 — Quality 41 · Valuation 74
| Share price | ₹151.40 |
| Market cap | ₹711 Cr |
| P/E ratio | 16.0 |
| P/B ratio | 1.5 |
| ROE | 86.3% |
| ROCE | 11.7% |
| Book value | ₹109.44 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹411 Cr | ₹38 Cr | 9.0% |
| 2025 | ₹327 Cr | ₹46 Cr | 12.0% |
| 2024 | ₹226 Cr | ₹27 Cr | 15.0% |
| 2023 | ₹194 Cr | ₹22 Cr | 13.0% |
| 2022 | ₹257 Cr | ₹23 Cr | 12.0% |
Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.